Table 5 Univariable logistic regression for the composite endpoint of an unfavorable postoperative outcome in the prospective cohort.
Variable | Composite endpoint | |
---|---|---|
OR [95% CI] | p-value | |
Clinical characteristics | ||
Age, years | 1.029 [0.989–1.071] | 0.156 |
eGFR, ml/min | 0.983 [0.966–1.001] | 0.061 |
Hematocrit, % | 0.920 [0.841–1.007] | 0.071 |
NYHA > II | 4.286 [1.768–10.387] | 0.001 |
Pulmonary hypertension* | 5.389 [1.130-25.702] | 0.035 |
Significant tricuspid regurgitation (grade ≥ 2) | 2.888 [0.840–9.931] | 0.092 |
Urgent/emergency procedure | 1.825 [0.623–5.345] | 0.272 |
3D LV echocardiographic parameters | ||
LVEDVi, ml/m² | 1.013 [0.995–1.032] | 0.166 |
LVESVi, ml/m² | 1.023 [1.002–1.045] | 0.030 |
LVEF, % | 0.975 [0.948–1.002] | 0.069 |
LV GLS, % | 1.031 [0.965–1.102] | 0.364 |
2D RV speckle-tracking echocardiography | ||
2D RV FWLS, % | 1.049 [0.989–1.113] | 0.114 |
2D RV GLS, % | 1.058 [0.983–1.138] | 0.132 |
ReVISION-derived 3D RV parameters | ||
RVEDVi, ml/m² | 1.026 [1.003–1.051] | 0.029 |
RVESVi, ml/m² | 1.053 [1.021–1.087] | 0.001 |
RVEF, % | 0.917 [0.871–0.964] | < 0.001 |
RV GLS, % | 1.176 [1.060–1.305] | 0.002 |
RV GCS, % | 1.157 [1.050–1.276] | 0.003 |
RV GAS, % | 1.115 [1.042–1.193] | 0.002 |
LEF, % | 0.913 [0.843–0.990] | 0.027 |
LEF/RVEF | 1.186 [0.013-107.128] | 0.941 |
AEF, % | 0.896 [0.834–0.963] | 0.003 |
AEF/RVEF | 0.039 [0.001–2.423] | 0.124 |
REF, % | 0.928 [0.874–0.986] | 0.015 |
REF/RVEF | 0.241 [0.011–5.067] | 0.360 |